CLSD - Clearside Biomedical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CLSD is currently covered by 4 analysts with an average price target of $-13.74. This is a potential upside of $-14.15 (-3451.22%) from yesterday's end of day stock price of $0.41.

Clearside Biomedical's activity chart (see below) currently has 73 price targets and 86 ratings on display. The stock rating distribution of CLSD is 71.43% BUY and 28.57% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 819.3 days.

Highest price target for CLSD is $5, Lowest price target is $5, average price target is $5.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 17-Nov-2025. First documented stock forecast 14-Aug-2016.

Currently out of the existing stock ratings of CLSD, 10 are a BUY (71.43%), 4 are a HOLD (28.57%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$3

1 months 24 days ago
(17-Nov-2025)

15/15 (100%)

$-6.03 (-66.78%)

450

Hold

$5

$2.28 (83.82%)

$5

5 months 24 days ago
(17-Jul-2025)

20/20 (100%)

$-1.14 (-18.57%)

557

Hold

$6

5 months 24 days ago
(17-Jul-2025)

3/3 (100%)

$-8.25 (-57.89%)

243

Buy

$5

$2.28 (83.82%)

$5

7 months 26 days ago
(15-May-2025)

9/9 (100%)

$-8.18 (-62.06%)

686

Buy

$5

$2.28 (83.82%)

$5

1 years 6 months 17 days ago
(24-Jun-2024)

2/2 (100%)

$-13.75 (-73.33%)

494

Show more analysts

Please expand the browser size to see the chart

What is CLSD (Clearside Biomedical) average time for price targets to be met?

On average it took 819.3 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on CLSD (Clearside Biomedical) with a proven track record?

LIANA MOUSSATOS

Which analyst has the most public recommendations on CLSD (Clearside Biomedical)?

Liana Moussatos works at WEDBUSH and has 5 price targets and 7 ratings on CLSD

Which analyst is the currently most bullish on CLSD (Clearside Biomedical)?

Zegbeh Jallah with highest potential upside - $14.28

Which analyst is the currently most reserved on CLSD (Clearside Biomedical)?

Serge Belanger with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?